Skip to main content

Table 2 Treatment received by RA and control patients after myocardial infarction

From: Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population

 

RA (n= 90)

Controls (n= 90)

    
 

n

%

n

%

Unadjusted ORa

(95% CI)

Adjusted ORb

(95% CI)

Acute reperfusionc

14

16

33

37

0.27

(0.10-0.64)

0.21

(0.07-0.62)

Thrombolysis

8

9

22

24

0.30

(0.10-0.77)

0.33

(0.11-0.96)

PCI

10

11

30

33

0.20

(0.06-0.53)

0.23

(0.09-0.63)

PCA

39

43

52

58

0.41

(0.16-0.92)

0.54

(0.23-1.25)

CABGS

11

12

17

19

0.57

(0.21-1.46)

0.67

(0.27-1.65)

  1. CABGS, coronary artery bypass graft surgery; CI, confidence interval; OR, odds ratio; PCA, percutaneous coronary angiography; PCI, percutaneous coronary intervention (angioplasty ± insertion of stent); RA, rheumatoid arthritis. aMcNemar χ2 test. bConditional logistic regression, adjusting for type of MI (STEMI or NSTEMI), presence of prior MI, and clinical setting of MI. cAcute reperfusion defined as the administration of thrombolysis or PCI within 12 hours of the first symptom of MI.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us